Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
- Author
- ABOU-ALFA, Ghassan K; SCHWARTZ, Lawrence; TAYLOR, Ian; MOSCOVICI, Marius; SALTZ, Leonard B; RICCI, Sergio; AMADORI, Dino; SANTORO, Armando; FIGER, Arie; DE GREVE, Jacques; DOUILLARD, Jean-Yves; LATHIA, Chetan; SCHWARTZ, Brian
[1] Memorial Sloan-Kettering Cancer Center, New York, NY, United States
[2] Bayer Pharmaceuticals Corporation, West Haven, CT, United States
[3] Ospedale S. Chiara, Pisa, Italy
[4] Ospedale Morgagni Pierantoni, Forii, Italy
[5] Istituto Clinico Humanitas, Rozzano (Ml), Italy
[6] Bayer S.p.A. PH/Medical Department, Milan, Italy
[7] Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
[8] AZ-VUB, Brussels, Belgium
[9] Centre Rend Gauducheau, Nantes, France - Source
Journal of clinical oncology. 2006, Vol 24, Num 26, pp 4293-4300, 8 p ; ref : 26 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- Lippincott Williams & Wilkins, Baltimore, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Cancer foie Cancérologie Carcinome hépatocellulaire Essai clinique phase II Homme Sorafénib Stade avancé Traitement Appareil digestif pathologie Foie pathologie Tumeur maligne
- Keyword (en)
- Antineoplastic agent Liver cancer Cancerology Hepatocellular carcinoma Phase II trial Human Sorafenib Advanced stage Treatment Digestive diseases Hepatic disease Malignant tumor
- Keyword (es)
- Anticanceroso Cáncer del hígado Cancerología Carcinoma hepatocelular Ensayo clínico fase II Hombre Sorafenib Estadio avanzado Tratamiento Aparato digestivo patología Hígado patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13C Liver. Biliary tract. Portal circulation. Exocrine pancreas / 002B13C01 Tumors
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18145725
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.2005.01.3441 
https://dx.doi.org/10.1200/JCO.2005.01.3441
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2005.01.3441\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Phase II study of sorafenib in patients with advanced hepatocellular carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"24\";s:8:\"\u0000*\u0000issue\";s:2:\"26\";s:8:\"\u0000*\u0000spage\";s:4:\"4293\";s:8:\"\u0000*\u0000epage\";s:4:\"4300\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ABOU-ALFA\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Ghassan K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:18:\"SCHWARTZ, Lawrence\";i:1;s:11:\"TAYLOR, Ian\";i:2;s:17:\"MOSCOVICI, Marius\";i:3;s:16:\"SALTZ, Leonard B\";i:4;s:13:\"RICCI, Sergio\";i:5;s:13:\"AMADORI, Dino\";i:6;s:16:\"SANTORO, Armando\";i:7;s:11:\"FIGER, Arie\";i:8;s:17:\"DE GREVE, Jacques\";i:9;s:20:\"DOUILLARD, Jean-Yves\";i:10;s:14:\"LATHIA, Chetan\";i:11;s:15:\"SCHWARTZ, Brian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Phase II study of sorafenib in patients with advanced hepatocellular carcinoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2005.01.3441\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Phase II study of sorafenib in patients with advanced hepatocellular carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"24\";s:8:\"\u0000*\u0000issue\";s:2:\"26\";s:8:\"\u0000*\u0000spage\";s:4:\"4293\";s:8:\"\u0000*\u0000epage\";s:4:\"4300\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ABOU-ALFA\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Ghassan K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:18:\"SCHWARTZ, Lawrence\";i:1;s:11:\"TAYLOR, Ian\";i:2;s:17:\"MOSCOVICI, Marius\";i:3;s:16:\"SALTZ, Leonard B\";i:4;s:13:\"RICCI, Sergio\";i:5;s:13:\"AMADORI, Dino\";i:6;s:16:\"SANTORO, Armando\";i:7;s:11:\"FIGER, Arie\";i:8;s:17:\"DE GREVE, Jacques\";i:9;s:20:\"DOUILLARD, Jean-Yves\";i:10;s:14:\"LATHIA, Chetan\";i:11;s:15:\"SCHWARTZ, Brian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Phase II study of sorafenib in patients with advanced hepatocellular carcinoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2005.01.3441\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2005.01.3441\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Phase II study of sorafenib in patients with advanced hepatocellular carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"24\";s:8:\"\u0000*\u0000issue\";s:2:\"26\";s:8:\"\u0000*\u0000spage\";s:4:\"4293\";s:8:\"\u0000*\u0000epage\";s:4:\"4300\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ABOU-ALFA\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Ghassan K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:18:\"SCHWARTZ, Lawrence\";i:1;s:11:\"TAYLOR, Ian\";i:2;s:17:\"MOSCOVICI, Marius\";i:3;s:16:\"SALTZ, Leonard B\";i:4;s:13:\"RICCI, Sergio\";i:5;s:13:\"AMADORI, Dino\";i:6;s:16:\"SANTORO, Armando\";i:7;s:11:\"FIGER, Arie\";i:8;s:17:\"DE GREVE, Jacques\";i:9;s:20:\"DOUILLARD, Jean-Yves\";i:10;s:14:\"LATHIA, Chetan\";i:11;s:15:\"SCHWARTZ, Brian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Phase II study of sorafenib in patients with advanced hepatocellular carcinoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2005.01.3441\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Phase II study of sorafenib in patients with advanced hepatocellular carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"24\";s:8:\"\u0000*\u0000issue\";s:2:\"26\";s:8:\"\u0000*\u0000spage\";s:4:\"4293\";s:8:\"\u0000*\u0000epage\";s:4:\"4300\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ABOU-ALFA\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Ghassan K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:18:\"SCHWARTZ, Lawrence\";i:1;s:11:\"TAYLOR, Ian\";i:2;s:17:\"MOSCOVICI, Marius\";i:3;s:16:\"SALTZ, Leonard B\";i:4;s:13:\"RICCI, Sergio\";i:5;s:13:\"AMADORI, Dino\";i:6;s:16:\"SANTORO, Armando\";i:7;s:11:\"FIGER, Arie\";i:8;s:17:\"DE GREVE, Jacques\";i:9;s:20:\"DOUILLARD, Jean-Yves\";i:10;s:14:\"LATHIA, Chetan\";i:11;s:15:\"SCHWARTZ, Brian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Phase II study of sorafenib in patients with advanced hepatocellular carcinoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
